Schizophrenic symptoms improve with apomorphine
- PMID: 347574
- DOI: 10.1126/science.347574
Schizophrenic symptoms improve with apomorphine
Abstract
Eighteen chronic schizophrenic patients received subcutaneous doses of apomorphine, a dopamine receptor agonist, and of placebo in separate trials. A significant improvement in psychotic symptoms occurred after apomorphine compared to placebo. The results are interpreted as a consequence of presynaptic dopamine receptor activation by apomorphine with a subsequent decrease in dopamine-mediated neural transmission.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources